Aytu BioPharma, Inc.
AYTU · NASDAQ
6/30/2025 | 6/30/2024 | 6/30/2023 | 6/30/2022 | |
|---|---|---|---|---|
| Market Cap | $13,690 | $15,783 | $5,344 | $20,286 |
| - Cash | $30,952 | $20,006 | $22,985 | $19,360 |
| + Debt | $22,937 | $16,418 | $30,426 | $18,188 |
| Enterprise Value | $5,675 | $12,195 | $12,785 | $19,114 |
| Revenue | $66,382 | $65,183 | $107,399 | $96,669 |
| % Growth | 1.8% | -39.3% | 11.1% | – |
| Gross Profit | $45,831 | $49,054 | $66,632 | $50,283 |
| % Margin | 69% | 75.3% | 62% | 52% |
| EBITDA | -$4,665 | $1,406 | -$3,273 | -$27,957 |
| % Margin | -7% | 2.2% | -3% | -28.9% |
| Net Income | -$13,562 | -$15,844 | -$17,051 | -$108,779 |
| % Margin | -20.4% | -24.3% | -15.9% | -112.5% |
| EPS Diluted | -2.16 | -2.86 | -5.11 | -74.01 |
| % Growth | 24.5% | 44% | 93.1% | – |
| Operating Cash Flow | -$1,937 | -$1,388 | -$5,129 | -$28,823 |
| Capital Expenditures | -$3,228 | -$329 | $0 | $0 |
| Free Cash Flow | -$5,165 | -$1,717 | -$5,129 | -$28,823 |